The trajectory of Viagra, originally marketed by copyright, presents a complex case study for investors considering the pharmaceutical sector. While its groundbreaking success and impact of vast in revenue , the exclusivity expiration has opened the floodgates for competing medications, substantially diminishing income opportunities. This shift rai